Framingham Heart Study
This study has been completed.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00005121
First received: May 25, 2000
Last updated: April 13, 2009
Last verified: April 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The Framingham Heart Study was initiated to study the factors associated with the development of cardiovascular disease by employing long-term surveillance of an adult population in Framingham, Massachusetts. The Framingham Offspring Study was initiated to assess familial and genetic factors as determinants of coronary heart disease.
| Condition |
|---|
|
Cardiovascular Diseases Heart Diseases Coronary Disease Cerebrovascular Accident Hypertension Heart Failure, Congestive Peripheral Vascular Diseases Arterial Occlusive Diseases Atherosclerosis Heart Failure |
| Study Type: | Observational |
Resource links provided by NLM:
MedlinePlus related topics:
Atherosclerosis
Coronary Artery Disease
Heart Diseases
Heart Failure
High Blood Pressure
Peripheral Arterial Disease
Vascular Diseases
U.S. FDA Resources
Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):
| Study Start Date: | July 1948 |
| Study Completion Date: | September 2008 |
| Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |
Show Detailed Description Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
No eligibility criteria
Contacts and Locations More Information
Additional Information:
No publications provided by National Heart, Lung, and Blood Institute (NHLBI)
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00005121 History of Changes |
| Other Study ID Numbers: | 900 |
| Study First Received: | May 25, 2000 |
| Last Updated: | April 13, 2009 |
| Health Authority: | United States: Federal Government |
Additional relevant MeSH terms:
|
Arterial Occlusive Diseases Atherosclerosis Cardiovascular Diseases Coronary Disease Coronary Artery Disease Heart Diseases Heart Failure Hypertension Cerebral Infarction Stroke Vascular Diseases |
Peripheral Vascular Diseases Peripheral Arterial Disease Arteriosclerosis Myocardial Ischemia Brain Infarction Brain Ischemia Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases |
ClinicalTrials.gov processed this record on June 17, 2013